|
Market Closed -
Euronext Paris
16:55:00 28/10/2026 GMT
|
5-day change | 1st Jan Change | ||
| 0.4220 EUR | -6.22% |
|
-23.27% | -64.18% |
| 10-22 | NFL Biosciences SA Reports Earnings Results for the Half Year Ended June 30, 2026 | CI |
| 10-22 | NFL Biosciences Gets Regulatory Approvals to Begin Phase 2 Nicotine Cessation Trial for NFL-102 | MT |
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| NFL BIOSCIENCES | Bio Therapeutic Drugs | -6.22% | -23.27% | -64.18% | -62.98% | -89.32% | 6.35M |  | | |
- Stock Market
- Stocks
- ALNFL Stock
- Charts NFL Biosciences
- Relative Strength Chart
Select your edition
All financial news and data tailored to specific country editions
